BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
4.980
-0.250 (-4.78%)
At close: Aug 22, 2025, 4:00 PM
5.00
+0.02 (0.40%)
After-hours: Aug 22, 2025, 7:59 PM EDT
BTAI's stock price has decreased by -54.26% in the past year and price targets may not have had time to catch up.
BioXcel Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$40.00
Upside
+703.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +100.80% | Aug 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +100.80% | Aug 15, 2025 |
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +1,225.30% | Jul 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $8 | Strong Buy | Maintains | $3 → $8 | +60.64% | Jun 23, 2025 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +1,205.22% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $48 | Strong Buy | Maintains | $80 → $48 | +863.86% | Jan 30, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $112 → $4 | Strong Buy → Sell | Downgrades | $112 → $4 | -19.68% | Jan 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $112 → $80 | Strong Buy | Maintains | $112 → $80 | +1,506.43% | Jan 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $112 → $80 | Strong Buy | Maintains | $112 → $80 | +1,506.43% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $112 | Strong Buy | Reiterates | $112 | +2,149.00% | Sep 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $112 | Strong Buy | Maintains | $112 | +2,149.00% | Aug 30, 2024 |
| UBS | UBS | Hold Maintains $56 → $16 | Hold | Maintains | $56 → $16 | +221.29% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $160 → $112 | Strong Buy | Maintains | $160 → $112 | +2,149.00% | Aug 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $112 | Strong Buy | Maintains | $112 | +2,149.00% | Jun 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +3,112.85% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +3,112.85% | Apr 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.